SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-11-012139
Filing Date
2011-02-23
Accepted
2011-02-23 09:26:57
Documents
2
Period of Report
2011-02-17

Document Format Files

Seq Description Document Type Size
1 rrd301920.html 3  
1 rrd301920.xml 3 2274
2 LIMITED POWER OF ATTORNEY rrd270640_305714.htm EX-24.1 3882
  Complete submission text file 0001181431-11-012139.txt   8046
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEGERION PHARMACEUTICALS, INC. 89 HEADQUARTERS PLAZA, SUITE 212 MORRISTOWN NJ 07960
Business Address
Tribble Diane L. (Reporting) CIK: 0001513462 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34921 | Film No.: 11630670